Lyra Therapeutics INC
-$696.2K
Net Activity
Institutions Holding
1
Popularity Rank
#20412
Avg Weight
0.57%
Total Value
$51.1K
1 institutions currently hold LYRA, with 0 net buyers and 21 net sellers this quarter.
Institutional Moves (Q1 2026)
Significantly Decreased
Based on recent trading activity
Net Selling Institutions
21
Net Buying Institutions
0
Top 5 by Value
Top 5 by Conviction
Across its top 1 institutional holders, LYRA's holder base skews toward high-concentration, high-turnover investors on average (avg. concentration score 100/100, avg. turnover score 78/100).
+$0.0
Total Buy Value
$747.2K
Total Sell Value
0
Net Buyers
21
Net Sellers
LYRA does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.
13F data as of 2026-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/LYRA
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
No Form 8-K filings for this ticker
55234L204
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter